Citadel Advisors - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 118 filers reported holding ANIKA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,410,144
+54.1%
129,369
+114.9%
0.00%
Q2 2023$1,563,840
+2.0%
60,194
+12.7%
0.00%
Q1 2023$1,533,906
-57.2%
53,409
-55.9%
0.00%
-100.0%
Q4 2022$3,583,465
+154.9%
121,063
+104.8%
0.00%
Q3 2022$1,406,000
+10.2%
59,107
+97.1%
0.00%
Q3 2021$1,276,000
-48.3%
29,985
-47.4%
0.00%
Q2 2021$2,467,000
+140.2%
56,984
+126.3%
0.00%
Q1 2021$1,027,000
+1.3%
25,184
+12.5%
0.00%
Q4 2020$1,014,000
-50.9%
22,384
-61.6%
0.00%
-100.0%
Q3 2020$2,065,000
+25.3%
58,365
+33.6%
0.00%
Q2 2020$1,648,000
-48.7%
43,680
-60.7%
0.00%
-100.0%
Q1 2020$3,214,000
-51.9%
111,162
-13.8%
0.00%
-66.7%
Q4 2019$6,685,000
-57.1%
128,938
-54.6%
0.00%
-57.1%
Q3 2019$15,596,000
+224.8%
284,131
+140.4%
0.01%
+250.0%
Q2 2019$4,801,000
-12.9%
118,177
-35.2%
0.00%0.0%
Q1 2019$5,511,000
+60.3%
182,259
+78.1%
0.00%0.0%
Q4 2018$3,438,000
-34.9%
102,309
-18.3%
0.00%0.0%
Q3 2018$5,281,000
-7.5%
125,196
-29.9%
0.00%0.0%
Q2 2018$5,712,000
+145.3%
178,509
+281.1%
0.00%
+100.0%
Q1 2018$2,329,000
-0.6%
46,845
+7.8%
0.00%0.0%
Q4 2017$2,343,000
+41.2%
43,459
+51.9%
0.00%0.0%
Q3 2017$1,659,000
-24.4%
28,609
-35.7%
0.00%0.0%
Q2 2017$2,195,000
+55.6%
44,488
+37.0%
0.00%0.0%
Q1 2017$1,411,000
-36.0%
32,475
-27.9%
0.00%
-50.0%
Q4 2016$2,204,000
+124.9%
45,033
+120.1%
0.00%
+100.0%
Q3 2016$980,000
+335.6%
20,463
+388.1%
0.00%
Q2 2016$225,000
-81.1%
4,192
-84.2%
0.00%
-100.0%
Q1 2016$1,189,000
+107.1%
26,585
+76.7%
0.00%
+100.0%
Q4 2015$574,000
+151.8%
15,042
+171.2%
0.00%
Q1 2015$228,000
-37.9%
5,547
-38.5%
0.00%
Q4 2014$367,000
+3977.8%
9,014
+3421.1%
0.00%
Q3 2014$9,000
-99.2%
256
-98.9%
0.00%
-100.0%
Q2 2014$1,088,000
+10.9%
23,504
-1.5%
0.00%0.0%
Q1 2014$981,000
+181.9%
23,851
+161.2%
0.00%
Q4 2013$348,000
+6.1%
9,132
-33.4%
0.00%
Q3 2013$328,000
+41.4%
13,717
+0.5%
0.00%
Q2 2013$232,00013,6510.00%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders